BioBridge: Innovation to Start-Up

Our upcoming event, “BioBridge: Innovation to Start-up” aims to connect and inspire early-career scientists with start-up founders who have successfully translated research ideas into entrepreneurial ventures. 

BioBridge event series started in 2025, organised by early career researchers of Postdocs in Flames and Turku Bioscience Centers ‘PhD–Postdoc board’ at University of Turku and Åbo Akademi University. This is the third instalment of the BioBridge events and the event is open to academics of all levels of University of Turku and Åbo Akademi University.

Confirmed Speakers (updated continuously):

CEO Olli Huhtinen, Evogence
CEO & Co-founder Preethy Paul, ATB Antivirals
CEO & Co-founder Manu Tamminen, Genomill
Founder, CSO, Board Member Jukka Westermarck, Thestra
CTO Zahra ”Elmira” Jahanshah Rad, SisuSemi and University of Turku
Collaboration Manager Antti Nuutinen, Entrepreneurial Hub Konttori, University of Turku
Process Manager John Holmberg and Co-founder & Coordinator Elias Savonlahti, Turku Startup Hub
Chief Innovation Advisor Jaana Rantanen, Business Finland
Professor of Practice Timo Veromaa, University of Turku
Head of Business Development Anne Marjamäki, Innovation Services, University of Turku

REGISTRATION IS OPEN!

Please register by May 1 here: https://eve.utu.fi/e/biobridge

More detailed programme coming soon!

Organising Committee
Postdocs in Flames (PiF) and Turku Bioscience Center’s ‘PhD-Postdoc board’ at University of Turku and Åbo Akademi University
InFLAMES Flagship’s Impact Team, University of Turku

The event is supported by Doctoral Programme in Immunology and ImmuDocs Doctoral Pilot Programme.